NB

Nathan Benaich

superinvesting

London, England

Invests in

Stages:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Solo Member of Superinvestment Staff

    2019

    Adept AI (acq. Amazon), Allcyte (acq. Exscientia), Anagenex, Athenian, CellVoyant, ClipDrop (acq. Stability.ai/Jasper), Enveda Biosciences, Exscientia (NASDAQ: EXAI, merged w/Recursion), Fern Labs, Gandeeva Therapeutics, Gourmey, Graphcore (acq. SoftBank), Hedera Dx, Intenseye, Interloom, LabGenius, Delian Alliance Industries, Mission Barns, Modern Intelligence, Odyssey, Patina Systems, Polar Mist, Poolside, Profluent, Recursion Pharmaceuticals (NASDAQ: RXRX), Samaya.ai, Sereact, Studio Atelico, Synthesia, V7, Valence Discovery (acq. Recursion), ZOE, and several unannounced.

  • Author

    2015

    Ideas worth propagating.

  • Author

    2018

    The definitive annual report on AI progress.

  • Founder

    2021

    Rewriting the university spinout playbook.

2017

  • Scientist in Residence

    2017

2013

  • Other things

    2013

    > Author: State of AI Report, Guide to AI newsletter. > Founded: RAAIS, RAAIS Foundation, London.AI > Angel: Tractable, Niantic (acq. Scopley), Wayve, Ndea, Lambda Labs, ElevenLabs, Recursion (NASDAQ: RXRX), Synthesia, Crusoe Energy, Optimal Labs, PolyAI, KyraTV, The Engineering Company, Secondmind, ONI.bio, Kepler Computing, 20bn (acq. Qualcomm), Motion, Muon Space, Detail, Incident.io, Quench, LabGenius, Synq, Kanna Health, Objective (acq. Upwork), Contextual.ai, Chroma, and All Hands AI. > Previously: Playfair Capital